Results 11 to 20 of about 1,361,126 (321)

Managing bevacizumab-induced intraocular inflammation

Indian Journal of Ophthalmology, 2012
The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies.
Subijay Sinha, Nagender Vashisht, Pradeep Venkatesh, Sat Pal Garg   +3 more
doaj   +3 more sources

Intraocular inflammation after intravitreal injection of faricimab–a case series including one case of bilateral choroidal involvement [PDF]

International Journal of Ophthalmology
AIM: To report and analyze cases of sterile intraocular inflammation (IOI) following intravitreal faricimab injections in patients treated for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Roman Lischke, Sarah-Maria Krause, Teresa Rauchegger, Gertrud Haas, Michal Koubek, Yvonne Nowosielski, Matus Rehak   +6 more
doaj   +2 more sources

Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy – An update

Indian Journal of Ophthalmology, 2020
Intraocular inflammation in patients with human immunodeficiency virus (HIV) infection is commonly due to infectious uveitis. Ocular lesions due to opportunistic infections (OI) are the most common and have been described extensively in the pre highly ...
Sridharan Sudharshan, Nivedita Nair, Andre Curi, Alay Banker, John H Kempen   +4 more
doaj   +2 more sources

Incidence of Postsurgical Intraocular Inflammation 6 Months After Implantation with a Multifocal Intraocular Lens [PDF]

Clinical Ophthalmology
James Paauw,1 Michael B Caplan,2 Mark Gallardo,3 Kristi Rushin,4 Jeffrey D Horn5 1Department of Ophthalmology, Piedmont Eye Center, Lynchburg, VA, USA; 2Berkeley Eye Center, Houston, TX, USA; 3El Paso Eye Surgeons, El Paso, TX, USA; 4Alcon Vision LLC ...
Paauw J, Caplan MB, Gallardo M, Rushin K, Horn JD   +4 more
doaj   +2 more sources

Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group [PDF]

Indian Journal of Ophthalmology
Context: Concerns about brolucizumab’s (Pagenax®) association with intraocular inflammation (IOI) limit its use despite its cost-effectiveness and efficacy.
Manisha Agarwal, Alankrita Muralidhar, Mahesh P Shanmugam, Abhishek Kothari, Ajay Dudani, Aniruddha Maiti, Anshu Arora, Chaitra Jayadev, Charu Gupta, Darius Shroff, Debdulal Chakraborty, Gopal S Pillai, Kairobi Lahiri, Lalit Verma, Mahesh Gopalakrishnan, Raja Narayanan, Sanjay K Mishra, Sanket Patil, Shailender Choudhary, Somnath Chakraborty, Sribhargava Natesh, Vikram Koundanya, Vinod Aggarwal   +22 more
doaj   +2 more sources

The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation

Frontiers in Immunology, 2019
CD4+ T cell mediated uveitis is conventionally treated with systemic immunosuppressive agents, including corticosteroids and biologics targeting key inflammatory cytokines. However, their long-term utility is limited due to various side effects. Here, we
Yanli Zou, Xiao Hu, Lauren P. Schewitz-Bowers, Lauren P. Schewitz-Bowers, Madeleine Stimpson, Madeleine Stimpson, Li Miao, Xiaofei Ge, Liu Yang, Yan Li, Paul W. Bible, Xiaofeng Wen, Jing Jing Li, Yizhi Liu, Richard W. J. Lee, Richard W. J. Lee, Lai Wei   +16 more
doaj   +2 more sources

Proactive Post-Injection Monitoring in Brolucizumab Therapy: A Study on Intraocular Inflammation and Treatment Outcomes [PDF]

Clinical Ophthalmology
Manoj Soman,1,2 Apoorva Jadhav,1,2 Abhaya Balakrishnan,1,2 Jay U Sheth,3 Unnikrishnan Nair1,2 1Department of Vitreoretinal Services, Chaithanya Eye Hospital and Research Institute, Trivandrum, India; 2Department of Research, Chaithanya Innovation in ...
Soman M, Jadhav A, Balakrishnan A, Sheth JU, Nair U   +4 more
doaj   +2 more sources

Epigenetic Modifications and Therapy in Uveitis

Frontiers in Cell and Developmental Biology, 2021
Uveitis is a sight-threatening intraocular inflammation, and the exact pathogenesis of uveitis is not yet clear. Recent studies, including multiple genome-wide association studies (GWASs), have identified genetic variations associated with the onset and ...
Yanli Zou, Yanli Zou, Jing Jing Li, Wei Xue, Xiangbin Kong, Hucheng Duan, Yiqun Li, Lai Wei   +7 more
doaj   +1 more source

Analysis of Intraocular Pressure Variation with Use of Steroid Eye Drops as Post-operative Medication in Cataract Patients [PDF]

International Journal of Scientific Research in Dental and Medical Sciences, 2022
Background and aim: Steroid drops are necessarily used after cataract surgery to control the ocular inflammation, but they can increase the intraocular pressure. Using two different steroid eye drops as post-operative medication after cataract surgery to
Suhani Malhotra, Prachi Shukla, Kopal Mithal, Suman Bhartiya, Vijay Singh, Mickey Dhamejani   +5 more
doaj   +1 more source

Detection and management of intraocular inflammation after brolucizumab treatment for neovascular age-related macular degeneration.

Ophthalmology Retina, 2023
PURPOSE To present interim descriptive insights from the OCTOPUS and SWIFT studies on incidence, clinical features, management, and outcomes of intraocular inflammation (IOI), vasculitis, and occlusive vasculitis with brolucizumab treatment (Beovu ...
B. Bodaghi, E. Souied, R. Tadayoni, M. Weber, A. Ponthieux, L. Kodjikian   +5 more
semanticscholar   +1 more source